# A Safety and Efficacy Study of Infusions of HepaStem in Urea Cycle Disorders Pediatric Patients

> **NCT03884959** · PHASE2 · WITHDRAWN · sponsor: **HLB Cell Co., Ltd.**

## Conditions studied

- Urea Cycle Disorder

## Interventions

- **BIOLOGICAL:** HepaStem Infusion

## Key facts

- **NCT ID:** NCT03884959
- **Lead sponsor:** HLB Cell Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-07-12
- **Primary completion:** 2020-11-04
- **Final completion:** 2020-11-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor decided to stop enrollment
- **Last updated:** 2020-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03884959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03884959, "A Safety and Efficacy Study of Infusions of HepaStem in Urea Cycle Disorders Pediatric Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03884959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*